Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Yajima

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Cancer Science|April 18, 2024
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinomaMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 3, 2022
Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinomaMasaaki Ito, Takaki Hiwasa, Satoshi Yajima, et al.
Surgery Today|August 16, 2020
What are the important prognostic factors in gastric cancer with positive duodenal margins? A multi-institutional analysisShohei Fujita, Yoko Oshima, Satoshi Yajima, et al.
Annals of Gastroenterological Surgery|July 3, 2025
Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional studyFumiaki Shiratori, Naoto Fujiwara, Yasuaki Nakajima, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 6, 2022
Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: multi-institutional study of the Japan Esophageal SocietyTakashi Suzuki, Satoshi Yajima, Akihiko Okamura, et al.
Surgery|February 26, 2021
Prognosis of hemodialysis patients undergoing surgery for gastric cancer: Results of a multicenter retrospective studyKotaro Sugawara, Hiroharu Yamashita, Satoshi Yajima, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|April 7, 2024
Prognostic Impact of Serum SCC Antigen in the 566 Upfront Surgery Group of Esophageal Squamous Cell Carcinoma: A Multi-Institutional Study of the Japan Esophageal SocietyTakashi Suzuki, Satoshi Yajima, Akihiko Okamura, et al.
Frontiers in Oncology|September 10, 2021
Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal CancerMasaaki Ito, Takaki Hiwasa, Yoko Oshima, et al.
Journal of Gastroenterology|April 24, 2015
NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancersYoko Oshima, Hideaki Shimada, Satoshi Yajima, et al.
Annals of Surgical Oncology|November 19, 2020
New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional StudySatoshi Yajima, Takashi Suzuki, Yoko Oshima, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Cancer Science|April 18, 2024
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinomaMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 3, 2022
Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinomaMasaaki Ito, Takaki Hiwasa, Satoshi Yajima, et al.
Surgery Today|August 16, 2020
What are the important prognostic factors in gastric cancer with positive duodenal margins? A multi-institutional analysisShohei Fujita, Yoko Oshima, Satoshi Yajima, et al.
Annals of Gastroenterological Surgery|July 3, 2025
Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional studyFumiaki Shiratori, Naoto Fujiwara, Yasuaki Nakajima, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 6, 2022
Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: multi-institutional study of the Japan Esophageal SocietyTakashi Suzuki, Satoshi Yajima, Akihiko Okamura, et al.
Surgery|February 26, 2021
Prognosis of hemodialysis patients undergoing surgery for gastric cancer: Results of a multicenter retrospective studyKotaro Sugawara, Hiroharu Yamashita, Satoshi Yajima, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|April 7, 2024
Prognostic Impact of Serum SCC Antigen in the 566 Upfront Surgery Group of Esophageal Squamous Cell Carcinoma: A Multi-Institutional Study of the Japan Esophageal SocietyTakashi Suzuki, Satoshi Yajima, Akihiko Okamura, et al.
Frontiers in Oncology|September 10, 2021
Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal CancerMasaaki Ito, Takaki Hiwasa, Yoko Oshima, et al.
Journal of Gastroenterology|April 24, 2015
NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancersYoko Oshima, Hideaki Shimada, Satoshi Yajima, et al.
Annals of Surgical Oncology|November 19, 2020
New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional StudySatoshi Yajima, Takashi Suzuki, Yoko Oshima, et al.
Pageof 8